Moderna Inc MRNA:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:52 PM EST
184.68
+5.68 (+3.17%)
+5.68 (+3.17%)Volume
2,663,210
52 week range
115.03 - 321.31
- Open179.12
- Day High184.88
- Day Low177.52
- Prev Close179.00
- 52 Week High321.31
- 52 Week High Date12/20/21
- 52 Week Low115.03
- 52 Week Low Date09/29/22
Key Stats
- Market Cap70.95B
- Shares Out384.18M
- 10 Day Average Volume3.20M
- Dividend-
- Dividend Yield-
- Beta1.73
- YTD % Change-27.23
KEY STATS
- Open179.12
- Day High184.88
- Day Low177.52
- Prev Close179.00
- 52 Week High321.31
- 52 Week High Date12/20/21
- 52 Week Low115.03
- 52 Week Low Date09/29/22
- Market Cap70.95B
- Shares Out384.18M
- 10 Day Average Volume3.20M
- Dividend-
- Dividend Yield-
- Beta1.73
- YTD % Change-27.23
RATIOS/PROFITABILITY
- EPS (TTM)27.65
- P/E (TTM)6.68
- Fwd P/E (NTM)23.55
- EBITDA (TTM)13.596B
- ROE (TTM)83.69%
- Revenue (TTM)21.39B
- Gross Margin (TTM)79.20%
- Net Margin (TTM)55.00%
- Debt To Equity (MRQ)6.37%
EVENTS
- Earnings Date02/22/2023(est)
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Latest On Moderna Inc
Content From Our Affiliates
Related Video
watch now
Profile
MOREModerna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States